東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Structure-Based Design and Developme...

Smith, Steven G.

FindBook

Google Book

Amazon

博客來

Structure-Based Design and Development of Small Molecule Modulators of the CBX7 Chromodomain.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Structure-Based Design and Development of Small Molecule Modulators of the CBX7 Chromodomain./
作者:	Smith, Steven G.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2017,
面頁冊數:	142 p.
附註:	Source: Dissertation Abstracts International, Volume: 78-07(E), Section: B.
Contained By:	Dissertation Abstracts International78-07B(E).
標題:	Molecular chemistry. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10257165
ISBN:	9781369571677

Structure-Based Design and Development of Small Molecule Modulators of the CBX7 Chromodomain.
Smith, Steven G.

Structure-Based Design and Development of Small Molecule Modulators of the CBX7 Chromodomain. - Ann Arbor : ProQuest Dissertations & Theses, 2017 - 142 p.

Source: Dissertation Abstracts International, Volume: 78-07(E), Section: B.

Thesis (Ph.D.)--Icahn School of Medicine at Mount Sinai, 2017.

Epigenetic writers, erasers, and readers make up a suite of proteins responsible for the modulation of gene transcription in the context of chromatin. The plethora of post-translational modifications (PTMs) that can be placed, removed, or recognized on histone tails provide different signals within the cell that alter gene expression without changing the underlying DNA sequence. Altered gene expression due to the dysregulation of these PTMs and the proteins that govern them is a common hallmark in various diseases, including numerous types of cancer. This thesis covers the discovery and development of two classes of small molecule modulators of an epigenetic reader domain, the chromodomain (ChD) of chromobox homolog 7 (CBX7), which is responsible for recognizing methylated lysine residues on histones. Members of the first class of compounds, led by the parent compound MS452 and the top-performing optimized compound MS0521, inhibit methyl-lysine recognition by occupying the peptide-binding groove of the CBX7 ChD, while members of the second class of compounds, including the parent compound MS351, is located squarely within the aromatic cage region of the CBX7 ChD, and has the unique ability to bind through the formation of a ternary complex with the protein and a strand of long noncoding RNA. While MS452-family compounds showed great promise in vitro, only MS351-family compounds have shown appreciable cellular efficacy. These small molecules serve as important probes that enable the in-depth study of the CBX7 ChD and the many proteins it associates with in the cell, and importantly, have the potential to be developed into novel therapeutics that can treat multiple varieties of cancer, including prostate cancer.

ISBN: 9781369571677Subjects--Topical Terms:

1071612
Molecular chemistry.

Structure-Based Design and Development of Small Molecule Modulators of the CBX7 Chromodomain.
LDR:02703nmm a2200301 4500 001 2153475
005 20171130090821.5
008 190424s2017 ||||||||||||||||| ||eng d
020 $a 9781369571677
035 $a (MiAaPQ)AAI10257165
035 $a AAI10257165
040 $a MiAaPQ $c MiAaPQ
100 1 $a Smith, Steven G. $3 776420
245 1 0 $a Structure-Based Design and Development of Small Molecule Modulators of the CBX7 Chromodomain.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2017
300 $a 142 p.
500 $a Source: Dissertation Abstracts International, Volume: 78-07(E), Section: B.
500 $a Adviser: Ming-Ming Zhou.
502 $a Thesis (Ph.D.)--Icahn School of Medicine at Mount Sinai, 2017.
520 $a Epigenetic writers, erasers, and readers make up a suite of proteins responsible for the modulation of gene transcription in the context of chromatin. The plethora of post-translational modifications (PTMs) that can be placed, removed, or recognized on histone tails provide different signals within the cell that alter gene expression without changing the underlying DNA sequence. Altered gene expression due to the dysregulation of these PTMs and the proteins that govern them is a common hallmark in various diseases, including numerous types of cancer. This thesis covers the discovery and development of two classes of small molecule modulators of an epigenetic reader domain, the chromodomain (ChD) of chromobox homolog 7 (CBX7), which is responsible for recognizing methylated lysine residues on histones. Members of the first class of compounds, led by the parent compound MS452 and the top-performing optimized compound MS0521, inhibit methyl-lysine recognition by occupying the peptide-binding groove of the CBX7 ChD, while members of the second class of compounds, including the parent compound MS351, is located squarely within the aromatic cage region of the CBX7 ChD, and has the unique ability to bind through the formation of a ternary complex with the protein and a strand of long noncoding RNA. While MS452-family compounds showed great promise in vitro, only MS351-family compounds have shown appreciable cellular efficacy. These small molecules serve as important probes that enable the in-depth study of the CBX7 ChD and the many proteins it associates with in the cell, and importantly, have the potential to be developed into novel therapeutics that can treat multiple varieties of cancer, including prostate cancer.
590 $a School code: 1734.
650 4 $a Molecular chemistry. $3 1071612
650 4 $a Biochemistry. $3 518028
650 4 $a Organic chemistry. $3 523952
690 $a 0431
690 $a 0487
690 $a 0490
710 2 $a Icahn School of Medicine at Mount Sinai. $b Pharmacology and System Biology. $3 3171738
773 0 $t Dissertation Abstracts International $g 78-07B(E).
790 $a 1734
791 $a Ph.D.
792 $a 2017
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10257165